← All trials
NCT01635790
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2012
- Primary completion
- Jun 1, 2016
- Completion date
- —
- First posted
- —
- Last posted
- —
- Enrollment
- 246
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Lead sponsor
- Leiden UniversityCollaborator
- Utrecht UniversityCollaborator
- University of GroningenCollaborator
- Radboud UniversityCollaborator
- University of AmsterdamOverall official - principal investigator
- University of AmsterdamSponsor investigator
- Erasmus University RotterdamCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.